|
|
| |
|
|
|
|
|
|
11085 |
¼¿ï |
2021³â ´ëÇѳëÀνŰæÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2021-12-04 |
0 |
295 |
2021-11-11 |
|
|
|
11084 |
ÀÎõ |
Èñ±ÍÁúȯ °æ±â¼ºÏºÎ±Ç °ÅÁ¡¼¾ÅÍ ½ÉÆ÷Áö¾ö : Èñ±ÍÀ¯ÀüÁúȯ Áø´Ü ¹× À¯Àü»ó´ãÀÇ ½ÇÁ¦ : 2021-12-03 |
0 |
198 |
2021-11-11 |
|
|
|
11083 |
°æ±â |
(¿Â¶óÀÎ) ±¹¸³¾Ï¼¾ÅÍ ¾Ï°úÇÐÆ÷·³, Ç׾Ͻžళ¹ß A-Z Part 2. Ç×ü ¹× Ä¡·á¿ë ¾Ï¹é½Å °³¹ß : 2021-12-03 |
0 |
365 |
2021-11-11 |
|
|
|
11082 |
°æ±â |
(¿Â¶óÀÎ) ´ëÇѼÒȱ⳻½Ã°æÇÐȸ °æ±âÀÎõÁöȸ Á¦9Â÷ ÇмúÁý´ãȸ : 2021-12-03 |
0 |
272 |
2021-11-11 |
|
|
|
11081 |
¼¿ï |
2021³â Áß¾ÓÀÇ´ë ºñ´¢À¶ÇÕ ¹× ¿À°¡³ëÀÌµå ¼¼¹Ì³ª : 2021-12-03 |
0 |
260 |
2021-11-11 |
|
|
|
11080 |
´ë±¸ |
´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ´ë±¸.°æºÏÁöȸ Á¦243Â÷ Áý´ãȸ : 2021-12-03 |
0 |
359 |
2021-11-11 |
|
|
|
11079 |
¼¿ï |
(¿Â¶óÀÎ) Á¦ 5ȸ ÀÇÇб³À°Æò°¡ ÄÁÆÛ·±½º : 2021-12-02 |
0 |
159 |
2021-11-11 |
|
|
|
11078 |
´ëÀü |
2021 ´ëÇÑ°¡Á¤ÀÇÇÐȸ ´ëÀüÁöȸ Ãß°èÇмú´ëȸ : 2021-12-02 |
0 |
190 |
2021-11-11 |
|
|
|
11077 |
¼¿ï |
2021 ¸¶Æ÷±¸ ÀÇ»çȸ ¿¬¼ö±³À° : 2021-12-02 |
0 |
218 |
2021-11-11 |
|
|
|
11076 |
°æ±â |
Çѱ¹¿©ÀÚÀÇ»çȸ Achieving optimal Low Density Lipoprotein-Cholesterol(LDL-C) Goal with Ezetimibe and Atorvastatin : 2021-12-02 |
0 |
231 |
2021-11-11 |
|
|
|
11075 |
¼¿ï |
Àü¹® ±âµµ°ü¸® ½Ã¹Ä·¹ÀÌ¼Ç ÈÆ·Ã : 2021-12-01 |
0 |
158 |
2021-11-11 |
|
|
|
11074 |
¼¿ï |
´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) 2021 CAUOS(Current Academic & Useful Orthopaedic Symposium) Seminar : 2021-12-01 |
0 |
462 |
2021-11-11 |
|
|
|
11073 |
´ë±¸ |
´ëÇÑÀçÈ°ÀÇÇÐȸ 105Â÷ ´ë±¸°æºÏÁöȸ Áý´ãȸ(Ultrasound-guided regenerative injection, ±Ù°ñ°Ý°è Áúȯ) : 2021-12-01 |
0 |
320 |
2021-11-11 |
|
|
|
11072 |
¼¿ï |
(¿Â¶óÀÎ)´ëÇÑÁø´Ü¸é¿ªÇÐȸ 2021³â Ãß°èÇмú´ëȸ : 2021-11-30 |
0 |
235 |
2021-11-11 |
|
|
|
11071 |
¼¿ï |
(¿Â¶óÀÎ) 2021³â ´ëÇѺñ°úÇÐȸ ¼ö¸é¿¬±¸È¸ : 2021-11-30 |
0 |
213 |
2021-11-11 |
|
|